EAM Investors, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 91 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$2,395,000
-46.5%
68,855
-44.8%
0.58%
-29.9%
Q1 2022$4,477,000
+84.0%
124,697
+2.0%
0.83%
+26.2%
Q4 2018$2,433,000
-23.7%
122,250
-29.3%
0.66%
+55.9%
Q4 2016$3,187,000
-13.1%
173,018
-10.5%
0.42%
-14.0%
Q3 2016$3,668,000
-7.8%
193,355
-21.7%
0.49%
-17.6%
Q2 2016$3,978,000
+231.8%
246,805
+261.8%
0.60%
+327.1%
Q2 2015$1,199,00068,2240.14%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2015
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders